MiNK Therapeutics stock: KDJ Death Cross, bearish Marubozu formation on 15min chart.

According to MiNK Therapeutics' 15-minute chart, a KDJ Death Cross and Bearish Marubozu signal was triggered on September 4, 2025 at 11:45. This indicates that the momentum of the stock price is shifting towards the downside, potentially leading to further decreases. Sellers currently dominate the market, and it is likely that bearish momentum will continue.

On September 4, 2025, at 11:45, MiNK Therapeutics' 15-minute chart triggered a KDJ Death Cross and Bearish Marubozu signal. These technical indicators suggest that the momentum of the stock price is shifting towards the downside, potentially leading to further decreases. The signals indicate that sellers currently dominate the market, and it is likely that bearish momentum will continue.

The KDJ Death Cross, where the K line crosses below the D line, reinforces the bearish bias, suggesting that the momentum of the stock price is shifting towards the downside. The Bearish Marubozu signal, characterized by a large gap between the open and close prices, further strengthens the bearish sentiment [1].

These technical indicators are corroborated by broader market trends, with other stocks such as Mingteng and Arrive AI exhibiting similar patterns, further validating the bearish signals [1, 2]. Despite the recent upgrade by H.C. Wainwright to a "Buy" rating from "Neutral," citing the company's Phase 2 gastric cancer data expected later this year as a significant catalyst for the shares, the technical indicators and broader market trends suggest a period of uncertainty and potential downward pressure on the stock price [3].

MiNK Therapeutics' strategic capital raises and non-dilutive grants have extended its cash runway to mid-2026, providing financial flexibility while advancing its pipeline. The company has been focusing on the development of its pipeline of iNKT cell therapies, including AGENT-797, which is advancing in Phase II trials for gastric cancer and immune-mediated diseases [4]. However, the recent technical indicators and broader market trends indicate that investors should remain vigilant and continue to monitor MiNK Therapeutics' stock performance, as well as the broader market trends, to make informed investment decisions.

References:
[1] https://www.ainvest.com/news/mink-therapeutics-bollinger-bands-narrowing-kdj-death-cross-15-minute-chart-2508-93/
[2] https://www.ainvest.com/news/mink-therapeutics-upgraded-buy-wainwright-upcoming-catalysts-2508/
[3] https://www.ainvest.com/news/hc-wainwright-upgrades-mink-therapeutics-buy-rating-35-price-target-2508/
[4] https://www.tipranks.com/stocks/inkt/technical-analysis